Li Yongbai, Gao Zhidong, Zhao Xuesong, Wang Bo, Ye Yingjiang, Wang Shan, Jiang Kewei
Department of Gastrointestinal Surgery, Peking University People's Hospital, Beijing 100044, China.
Zhonghua Wei Chang Wai Ke Za Zhi. 2018 May 25;21(5):569-577.
To study the clinicopathological features and prognosis of gastric stump cancer (GSC) following subtotal gastrectomy for gastric cancer, to compare the clinicopathologic differences between narrow GSC and generalized GSC, and to compare the prognosis between GSC and primary proximal gastric cancer (PPGC) after radical resection.
Literatures of GSC-associated clinical study were searched by computer from the Cochrane Library, Medline, PubMed, CNKI, Wanfang and VIP databases, and the retrieval period was from the establishment of database to December 31, 2017.
(1) GSC was defined as a carcinoma arising in the gastric remnant after radical gastrectomy for gastric cancer, and confirmed by the pathological or histological examination, the elapsed time from the initial operation was not considered in the definition. (2) Retrospective or prospective clinical cohort study. (3) Study included at least one of below items: gender, anastomotic type in gastric cancer surgery, the interval between the initial surgery and diagnosis of GSC, the location, treatment, pathological differentiation, pathologic stage, lymph node metastasis rate and prognosis of GSC. (4) When similar studies were reported by the same institution or author, either the better quality study or the newest publication was chosen.
(1) Abstracts, reviews, case reports, meeting record, editorials and repeated research. (2) Studies including patients with initial non-gastric cancer. In this study, gastric stump cancer(GSC) after gastric cancer was divided into two groups: the incidence without limit interval time (generalized GSC group) and above 10 years (narrow GSC group). Selective trials were Meta-analyzed by the Stata13.0 software and statistical analysis was performed using SPSS 21.0 software.
A total of 27 literatures were finally enrolled, which comprised 1463 GSC patients, including 1146 males and 317 females. The generalized group and narrow GSC group had 921 and 542 patients respectively. The generalized GSC group and the narrow GSC group did not significantly differ in terms of previous reconstruction mode, types of differentiation, pathologic T staging, postoperative pathology tumor-node-metastases staging, and distant metastasis rate (χ=2.341, 0.926, 0.350, 0.965, 2.311 respectively, all P>0.05). As compared to generalized GSC group, narrow GSC group had higher ratio of male patients (82.8% vs. 75.7%, χ=9.909, P=0.002), more lesions locating in anastomotic stoma (37.8% vs. 26.1%, χ=18.091, P=0.000), higher ratio of patients undergoing radical resection (84.2% vs. 70.3%, χ=11.738, P=0.001), higher positive rate of postoperative lymph node (45.8% vs. 34.5%, χ=6.319, P=0.012), and larger size of tumor [(5.9±2.2) cm vs. (4.5±1.9) cm, t=9.151, P=0.000]. The overall 5-year survival rate and postoperative pathology stage III(-IIII( survival ratio in narrow GSC group were higher compared to general GSC group (42.7% vs. 30.6% and 27.5% vs. 18.1%, respectively), which were significantly different (χ=10.938, P=0.000; χ=4.128, P=0.042), while the postoperative pathology stage I(-II( survival ratio was not significantly different between two groups (67.3% vs. 67.0% respectively, χ=0.015, P=0.92). There was no significant difference in the 5-year survival rate between GSC with radical resection and PPGC(RR=1.04, 95%CI:0.79-1.36, P=0.805) and the 5-year survival rate of same postoperative pathology stage was not significantly different between two groups (I(-II( stage: RR=1.08, 95%CI:0.93-1.26, P=0.328; III(-IIII( stage: RR=0.59, 95%CI:0.33-1.04, P=0.111).
There are some different clinicopathological features between the generalized and the narrow GSC after gastric cancer surgery. The prognosis of GSC after radical resection is similar to primary proximal gastric cancer.
研究胃癌根治性胃大部切除术后残胃癌(GSC)的临床病理特征及预后,比较局限性GSC与广泛性GSC的临床病理差异,以及根治性切除术后GSC与原发性近端胃癌(PPGC)的预后。
通过计算机检索Cochrane图书馆、Medline、PubMed、中国知网、万方和维普数据库中与GSC相关的临床研究文献,检索时间从各数据库建库至2017年12月31日。
(1)GSC定义为胃癌根治性胃大部切除术后胃残端发生的癌,经病理或组织学检查确诊,定义中不考虑初次手术至确诊的时间间隔。(2)回顾性或前瞻性临床队列研究。(3)研究至少包括以下项目之一:性别、胃癌手术吻合方式、初次手术至GSC诊断的间隔时间、GSC的部位、治疗、病理分化程度、病理分期、淋巴结转移率及预后。(4)同一机构或作者报道的相似研究,选择质量较好或最新发表的研究。
(1)摘要、综述、病例报告、会议记录、社论及重复研究。(2)纳入初次诊断非胃癌患者的研究。本研究将胃癌术后残胃癌分为两组:无时间间隔限制发生率组(广泛性GSC组)和间隔时间大于10年组(局限性GSC组)。采用Stata13.0软件对纳入的试验进行Meta分析,并用SPSS 21.0软件进行统计分析。
最终纳入27篇文献,共1463例GSC患者,其中男性1146例,女性317例。广泛性GSC组和局限性GSC组分别有921例和542例患者。广泛性GSC组和局限性GSC组在既往重建方式、分化类型、病理T分期、术后病理肿瘤-淋巴结-转移分期及远处转移率方面差异均无统计学意义(χ值分别为2.341、0.926、0.350、0.965、2.311,均P>0.05)。与广泛性GSC组相比,局限性GSC组男性患者比例更高(82.8%对75.7%,χ=9.909,P=0.002),病变位于吻合口处的比例更高(37.8%对26.1%,χ=18.091,P=0.000),接受根治性切除的患者比例更高(84.2%对70.3%,χ=11.738,P=0.001),术后淋巴结阳性率更高(45.8%对34.5%,χ=6.319,P=0.012),肿瘤直径更大[(5.9±2.2)cm对(4.5±1.9)cm,t=9.151,P=0.000]。局限性GSC组的总体5年生存率及术后病理Ⅲ(-Ⅳ)期生存率均高于广泛性GSC组(分别为42.7%对30.6%和27.5%对18.1%),差异有统计学意义(χ=10.938,P=0.000;χ=4.128,P=0.042),而术后病理Ⅰ(-Ⅱ)期生存率两组间差异无统计学意义(分别为67.3%对67.0%,χ=0.015,P=0.92)。GSC根治性切除术后与PPGC的5年生存率差异无统计学意义(RR=1.04,95%CI:0.79-1.36,P=0.805),相同术后病理分期的5年生存率两组间差异亦无统计学意义(Ⅰ-Ⅱ期:RR=1.08,95%CI:0.93-1.26,P=0.328;Ⅲ-Ⅳ期:RR=0.59,95%CI:0.33-1.04,P=0.111)。
胃癌手术后广泛性和局限性GSC存在一些不同的临床病理特征。根治性切除术后GSC的预后与原发性近端胃癌相似。